Supriya Lifescience Limited (BOM:543434)
India
· Delayed Price · Currency is INR 728.15
+3.95 (0.55%)
At close: Jul 2, 2025
Supriya Lifescience Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2018 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2018 - 2020 |
Net Income | 1,880 | 1,191 | 898.57 | 1,518 | 1,236 | Upgrade
|
Depreciation & Amortization | 204.44 | 154.45 | 114.52 | 97.52 | 63.69 | Upgrade
|
Other Amortization | - | 3.66 | 3.63 | 3.66 | 3.92 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.06 | - | 1.11 | - | - | Upgrade
|
Other Operating Activities | -53.72 | -44.76 | -43.63 | -87.74 | 123.52 | Upgrade
|
Change in Accounts Receivable | -226.79 | -270.19 | 305.19 | -416.83 | -218.7 | Upgrade
|
Change in Inventory | -331 | 305.21 | -234.58 | -198.32 | -230.22 | Upgrade
|
Change in Accounts Payable | 149.76 | -46.59 | 152.56 | -20.5 | 16.53 | Upgrade
|
Change in Other Net Operating Assets | 24.42 | -159.85 | -561.32 | -407.88 | -235.78 | Upgrade
|
Operating Cash Flow | 1,647 | 1,133 | 636.05 | 488.01 | 758.89 | Upgrade
|
Operating Cash Flow Growth | 45.34% | 78.14% | 30.34% | -35.69% | -34.61% | Upgrade
|
Capital Expenditures | -1,624 | -1,457 | -1,079 | -599.04 | -482.41 | Upgrade
|
Sale of Property, Plant & Equipment | - | - | - | 0.82 | 14.4 | Upgrade
|
Investment in Securities | 5.56 | -385 | -252.43 | - | - | Upgrade
|
Other Investing Activities | 95.76 | 105.8 | 94.99 | - | - | Upgrade
|
Investing Cash Flow | -1,522 | -1,736 | -1,237 | -598.22 | -468.01 | Upgrade
|
Short-Term Debt Repaid | - | -166.25 | -46.7 | -486.07 | -92.73 | Upgrade
|
Long-Term Debt Repaid | -1.08 | -3.54 | -2.78 | -7.63 | -23.93 | Upgrade
|
Total Debt Repaid | -1.08 | -169.79 | -49.48 | -493.7 | -116.66 | Upgrade
|
Net Debt Issued (Repaid) | -1.08 | -169.79 | -49.48 | -493.7 | -116.66 | Upgrade
|
Issuance of Common Stock | - | - | - | 2,000 | - | Upgrade
|
Common Dividends Paid | -64.39 | -48.29 | -48.29 | -43.91 | -39.56 | Upgrade
|
Other Financing Activities | -16.86 | -5.51 | -4.99 | 34.13 | 11.06 | Upgrade
|
Financing Cash Flow | -82.33 | -223.59 | -102.76 | 1,497 | -145.16 | Upgrade
|
Miscellaneous Cash Flow Adjustments | - | 0.01 | -0.01 | - | 0.01 | Upgrade
|
Net Cash Flow | 41.98 | -826.26 | -703.26 | 1,386 | 145.73 | Upgrade
|
Free Cash Flow | 22.99 | -323.48 | -443.05 | -111.03 | 276.48 | Upgrade
|
Free Cash Flow Growth | - | - | - | - | -69.80% | Upgrade
|
Free Cash Flow Margin | 0.33% | -5.67% | -9.61% | -2.10% | 7.07% | Upgrade
|
Free Cash Flow Per Share | 0.29 | -4.02 | -5.50 | -1.38 | 3.78 | Upgrade
|
Cash Interest Paid | 16.86 | 5.51 | 4.99 | 36.58 | 38.74 | Upgrade
|
Cash Income Tax Paid | 591.79 | 376.45 | 306.8 | 609.62 | 299.94 | Upgrade
|
Levered Free Cash Flow | -203.5 | -528.68 | -582.63 | -165.84 | 73.81 | Upgrade
|
Unlevered Free Cash Flow | -192.97 | -496.5 | -563.35 | -139.6 | 99.31 | Upgrade
|
Change in Net Working Capital | 275.85 | 199.57 | 334.7 | 918.86 | 525.8 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.